IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 652.11 USD -0.9% Market Closed
Market Cap: 52.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-7%
Revenue
Forecast
+8%
Operating Income
Forecast
+13%
Net Income
Forecast
+12%

Wall Street
Price Targets

IDXX Price Targets Summary
IDEXX Laboratories Inc

Wall Street analysts forecast IDXX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDXX is 604.34 USD with a low forecast of 393.82 USD and a high forecast of 824.25 USD.

IDXX Lowest Forecast
Wall Street Target
393.82 USD
40% Downside
IDXX Average Forecast
Wall Street Target
604.34 USD
7% Downside
IDXX Highest Forecast
Wall Street Target
824.25 USD
26% Upside
Lowest
Price Target
393.82 USD
40% Downside
Average
Price Target
604.34 USD
7% Downside
Highest
Price Target
824.25 USD
26% Upside
IDEXX Laboratories Inc Competitors:
Price Targets
BDX
Becton Dickinson and Co
16% Upside
PDEX
Pro-Dex Inc
49% Upside
ANGO
AngioDynamics Inc
120% Upside
S
STXS
Stereotaxis Inc
81% Upside
BDX
Becton Dickinson and Co
16% Upside
PDEX
Pro-Dex Inc
49% Upside
ANGO
AngioDynamics Inc
120% Upside
S
STXS
Stereotaxis Inc
81% Upside
E
ELMD
Electromed Inc
76% Upside
DCTH
Delcath Systems Inc
133% Upside

Revenue
Forecast

Revenue Estimate
IDEXX Laboratories Inc

For the last 13 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 9%. The projected CAGR for the next 3 years is 8%.

9%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
IDEXX Laboratories Inc

For the last 13 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 13%. The projected CAGR for the next 3 years is 13%.

13%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
IDEXX Laboratories Inc

For the last 13 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 14%. The projected CAGR for the next 3 years is 12%.

14%
Past Growth
12%
Estimated Growth
Estimates Accuracy
11%
Average Beat
What are analyst estimates?

See Also

Summary
IDXX intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDXX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDXX stock valuation using valuation multiples.
Wall Street Estimates
IDXX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDXX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDXX's stock price target?
Price Target
604.34 USD

According to Wall Street analysts, the average 1-year price target for IDXX is 604.34 USD with a low forecast of 393.82 USD and a high forecast of 824.25 USD.

What is IDEXX Laboratories Inc's Revenue forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 9%. The projected CAGR for the next 3 years is 8%.

What is IDEXX Laboratories Inc's Operating Income forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 13%. The projected CAGR for the next 3 years is 13%.

What is IDEXX Laboratories Inc's Net Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 14%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 274,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.